Novo Nordisk
NVO
#66
Rank
A$348.35 B
Marketcap
A$67.87
Share price
9.92%
Change (1 day)
-50.05%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): A$32.58 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are A$47.21 Billion. In 2024 the company made an earning of A$26.96 Billion, an increase over its 2023 earnings that were of A$21.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$32.58 B20.87%
2024 A$26.96 B22.84%
2023 A$21.95 B57.81%
2022 A$13.90 B5.24%
2021 A$13.21 B12.38%
2020 A$11.76 B13.11%
2019 A$10.39 B-3.45%
2018 A$10.76 B1.88%
2017 A$10.57 B4.3%
2016 A$10.13 B10.32%
2015 A$9.18 B7.47%
2014 A$8.54 B3.4%
2013 A$8.26 B19.09%
2012 A$6.94 B15.58%
2011 A$6.00 B16.58%
2010 A$5.15 B25.66%
2009 A$4.10 B10.68%
2008 A$3.70 B55.82%
2007 A$2.37 B7.02%
2006 A$2.22 B19.05%
2005 A$1.86 B10.55%
2004 A$1.68 B
2002 A$1.18 B-14.39%
2001 A$1.38 B-52.82%
2000 A$2.94 B250%
1999 A$0.84 B31.21%
1998 A$0.64 B34.31%
1997 A$0.47 B11.46%
1996 A$0.42 B9.03%
1995 A$0.39 B-3.15%
1994 A$0.40 B-0.67%
1993 A$0.40 B45.38%
1992 A$0.28 B-13.81%
1991 A$0.32 B37.12%
1990 A$0.23 B-0.79%
1989 A$0.23 B26.2%
1988 A$0.18 B24.97%
1987 A$0.15 B-0.9%
1986 A$0.15 B-7.78%
1985 A$0.16 B24.87%
1984 A$0.13 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$16.88 B-43.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.06 B 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$12.96 B-56.34%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$11.44 B-61.46%๐Ÿ‡บ๐Ÿ‡ธ USA